CARDIEX LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.06 AUD | -4.76% |
|
-7.69% | -55.56% |
| 04-02 | Australian Shares Inch Down As Market Assesses RBA Policy Meeting Minutes | MT |
| 04-02 | Cardiex Marks Two Milestones Toward Wearable Biomarker Technology Commercialization; Shares Up 5% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
CardieX Limited is an Australia-based digital health technology company. The Company develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Companyâs SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.
Calendar
2024-08-28
- Q4 2024 Earnings Release (Projected)
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -55.56% | 12.38M | |
| +7.31% | 217B | |
| +12.99% | 194B | |
| +19.71% | 143B | |
| +30.60% | 111B | |
| +0.65% | 64.3B | |
| +15.23% | 52.94B | |
| +2.06% | 49.53B | |
| -5.49% | 38.31B | |
| -0.22% | 35.22B |
- Stock Market
- Equities
- CDX Stock
- News CardieX Limited
- CardieX Acquires Wearable Sensor Startup Blumio
